Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

Rosaria Di Lorenzo,1 Paola Ferri,2 Michela Cameli,3 Sergio Rovesti,4 Chiara Piemonte5 1Psychiatric Intensive Treatment Facility, Department of Mental Health and Drug Abuse, AUSL Modena, Modena, Italy; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia,...

Full description

Bibliographic Details
Main Authors: Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Paliperidone Palmitate once-monthly Haloperidol decanoate Aripiprazole prolonged release once-monthly Schizophrenia relapses and clinical course Long-acting treatment effectiveness. First generation antipsychotics Second generation antipsychotics
Online Access:https://www.dovepress.com/effectiveness-of-1-year-treatment-with-long-acting-formulation-of-arip-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/effectiveness-of-1-year-treatment-with-long-acting-formulation-of-arip-peer-reviewed-article-NDT

Similar Items